ImmunoGen Inc. (Nasdaq: IMGN) will offer $100 million in convertible senior notes through a private placement. Shares of the biotechnology firm plummeted $1.46 to close at $3.49.
ImunoGen to offer notes
June 14, 2016 at 16:52 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.